![Michael Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael F.
Huang worked as Chief Medical Officer at Spruce Biosciences, Inc. from 2017 to 2020, at AmMax Bio, Inc. from 2020 to 2022, and at DTx Pharma, Inc. from 2022 to 2023.
Education includes undergraduate studies at the University of California, Berkeley, and a doctorate from Chicago Medical School.
Anciens postes connus de Michael Huang
| Sociétés | Poste | Fin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 15/05/2026 |
DTx Pharma, Inc.
 DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Directeur Technique/Scientifique/R&D | 01/01/2023 |
AmMax Bio, Inc.
 AmMax Bio, Inc. BiotechnologyHealth Technology Operates a clinical stage biotech company | Directeur Technique/Scientifique/R&D | 01/05/2022 |
| SPRUCE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/02/2020 |
Formation de Michael Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DTx Pharma, Inc.
DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders | Health Technology |
AmMax Bio, Inc.
AmMax Bio, Inc. BiotechnologyHealth Technology Operates a clinical stage biotech company | Health Technology |
